Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer

Weide Zhong(Guangzhou First People's Hospital), Jun-chen Liu(Texas A&M Health Science Center)
OncoTargets and Therapy
April 1, 2016
Cited by 120


Related Papers